Skip links

PALSONIFY™ (paltusotine)

Full Name PALSONIFY™ (paltusotine)
Drug paltusotine
Manufacturer Crinetics Pharmaceuticals, Inc.
Route of Administration Oral
Site of Care Home
Approved Indication The treatment of adults with acromegaly who had an inadequate response to surgery and/or for whom surgery is not an option
Disease Acromegaly
Therapeutic Area Endocrinology
Enrollment Form Link Enrollment Form
Phone Number 847-239-5680
Fax Number 847-892-1203
Product Website palsonify.com